FLPUTNAM INVESTMENT MANAGEMENT CO
Position in TRVI — Trevi Therapeutics, Inc.
CIK 1140334
PORTLAND, ME
Position in TRVI
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$12,685,180
-$503,726 QoQ
Shares Held
1,063,301
+0.9% QoQ
Ownership
0.749%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 20.128919280617623.ToString("F0")%
Shared 0.ToString("F0")%
None 79.87108071938238.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FLPUTNAM INVESTMENT MANAGEMENT CO holds $37,680,376 across 10 Biotechnology names. TRVI ranks #2 (33.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
39,498 | $17,637,436 | |
| 2 | TRVI |
Trevi Therapeutics, Inc.
This page
|
1,063,301 | $12,685,180 | |
| 3 | ZVRA |
Zevra Therapeutics, Inc.
|
350,501 | $3,266,669 | |
| 4 | KZIA |
Kazia Therapeutics Ltd
|
142,469 | $1,059,969 | |
| 5 | CRDF |
Cardiff Oncology, Inc.
|
595,127 | $964,105 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,741 | $906,914 | |
| 7 | GNLX |
GENELUX Corp
|
280,904 | $679,787 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
454 | $350,778 |
All Filings in TRVI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,685,180 | 1,063,301 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $13,188,906 | 1,053,427 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $9,590,133 | 1,048,102 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $475,627 | 86,952 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||